The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
The EuropeaN Guidelines for the mAnagement of Graft rEcipients (ENGAGE) is an initiative from the European Society for Organ Transplantation (ESOT).
ENGAGE II working group published an updated definition of sensitisation in candidates for solid organ transplantation (Bestard et al., Transpl Int, 2021, 34: 1005–1018) suggesting that data from the patient’s “immunological” history should be integrated with single-antigen bead assay and cytotoxic (CDC) and flow cytometry cross-matching to enable their risk of antibody-mediated rejection (AMR) and graft loss to be estimated and stratified into one of five categories. Building on this first step, the ENGAGE II working group performed a systematic search evaluating the Induction Therapies, Antibody Removal Strategies and New Biological Drugs and Maintenance immunosuppression, and these data have been synthesised in a white paper that has been the basis for the rationale of the following step, the ENGAGE consensus project.
The project, based on the Delphi methodology, was aimed at obtaining a consensus among European experts on desensitization and immunomodulation of kidney recipients, according to defined pre-transplantation patient humoral risk profiles. Desensitisation strategies are employed before the transplantation to prevent hyperacute rejection in patients with high levels of preformed DSA and, therefore, increase the transplant candidate’s access to transplantation. In contrast, the modulation of induction and maintenance immunosuppression (including the use of Antibody Removal Strategies) can be adjusted from day 0 onward according to the risk profile of the recipient in order to reduce his risk of subsequent AMR and graft loss.
The ENGAGE II working group final paper titled “European consensus on the management of sensitized kidney transplant recipients: a Delphi study” was accepted for publication on Transplant International (TI), in March 2024.
This project is possible thanks to unrestricted grants from Hansa.
The scientific programme can be viewed here:
Scientific Organising Committee
Lucrezia Furian (Italy)
Olivier Thaunat(France)
Oriol Bestard (Spain)
Georg Böhmig (Austria)
Emanuele Cozzi (Italy)
Maarten Naesens (Belgium)
Søren Schwartz Sørensen (Denmark)
Ondřej Viklický (Czech Republic)
Workshop Venue
Melia Sky Barcelona
Pere IV, 272 – 286
Barcelona
Project Coordinator
Supriya Barve – supriya.barve@esot.org
This project is possible thanks to unrestricted grants from Hansa.
